Role of conservation therapy for invasive lobular carcinoma of the breast

被引:0
|
作者
Michael Bouvet
David W. Ollila
Kelly K. Hunt
Gildy V. Babiera
Francis R. Spitz
Armando E. Giuliano
Eric A. Strom
Frederick C. Ames
Merrick I. Ross
S. Eva Singletary
机构
[1] The University of Texas M. D. Anderson Cancer Center,Dept. of Surgical Oncology, Box 106
[2] The University of Texas M. D. Anderson Cancer Center,the Department ofRadiation Oncology
[3] The John Wayne Cancer Institute,the Department of Surgical Oncology
来源
关键词
Breast cancer; Breast conservation surgery; Invasive lobular cancer; Radiation therapy;
D O I
暂无
中图分类号
学科分类号
摘要
Background: Invasive lobular carcinoma (ILC) accounts for 5% to 10% of all invasive breast cancers. Although breast conservation therapy using local excision and postoperative irradiation is a standard therapy for early invasive ductal breast cancer, the result of this strategy in ILC is not well documented. We sought to determine the rate of locoregional recurrence after breast conservation therapy in patients with ILC.
引用
收藏
页码:650 / 654
页数:4
相关论文
共 50 条
  • [1] Role of conservation therapy for invasive lobular carcinoma of the breast
    Bouvet, M
    Ollila, DW
    Hunt, KK
    Babiera, GV
    Spitz, FR
    Giuliano, AE
    Strom, EA
    Ames, FC
    Ross, MI
    Singletary, SE
    ANNALS OF SURGICAL ONCOLOGY, 1997, 4 (08) : 650 - 654
  • [2] CONSERVATION THERAPY FOR INVASIVE LOBULAR CARCINOMA OF THE BREAST
    PAGE, DL
    CANCER, 1993, 71 (01) : 277 - 277
  • [3] CONSERVATION THERAPY FOR INVASIVE LOBULAR CARCINOMA OF THE BREAST
    POEN, JC
    TRAN, L
    JUILLARD, G
    SELCH, MT
    GIULIANO, A
    SILVERSTEIN, M
    FINGERHUT, A
    LEWINSKY, B
    PARKER, RG
    CANCER, 1992, 69 (11) : 2789 - 2795
  • [4] Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma
    Vo, Thao N.
    Meric-Bernstam, Funda
    Yi, Min
    Buchholz, Thomas A.
    Ames, Frederick C.
    Kuerer, Henry M.
    Bedrosian, Isabelle
    Hunt, Kelly K.
    AMERICAN JOURNAL OF SURGERY, 2006, 192 (04): : 552 - 555
  • [5] The role of fibroblasts in invasive lobular breast carcinoma
    Boelens, Mirjam C.
    Wientjens, Ellen
    Schut, Eva
    Klarenbeek, Sjoerd
    de Visser, Karin E.
    Jonkers, Jos
    CANCER RESEARCH, 2015, 75 (01)
  • [6] Adjuvant antihormonal Therapy in invasive lobular Breast Carcinoma
    Danzinger, Autoren S.
    Trinkl, C.
    Metzler, J.
    Izso, M.
    Hielscher, N.
    Pfeifer, C.
    Tendl-Schulz, K.
    Singer, C. F.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2021, 81 (04) : E6 - E6
  • [7] Invasive Lobular Carcinoma of the Breast: Toward Tailoring Therapy?
    Djerroudi, Lounes
    Cabel, Luc
    Bidard, Francois-Clement
    Vincent-Salomon, Anne
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2022, 114 (11): : 1434 - 1436
  • [8] Treatment of invasive lobular carcinoma with breast conserving therapy
    Tulusan, A. H.
    Buehner, M.
    Popovich, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] Breast conservation therapy for invasive lobular carcinoma: The impact of lobular carcinoma in situ in the surgical specimen on local recurrence and axillary node status
    Stolier, AJ
    Barre, G
    Bolton, JS
    Fuhrman, GM
    Looney, S
    AMERICAN SURGEON, 2004, 70 (09) : 818 - 821
  • [10] The role of androgen receptor in invasive lobular breast carcinoma
    Stires, Hillary
    Riggins, Rebecca B.
    CANCER RESEARCH, 2017, 77